These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25986372)

  • 1. Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria.
    Meloni ST; Chaplin B; Chang C; Rawizza H; Okonkwo P; Kanki PJ
    Curr HIV Res; 2015; 13(3):210-8. PubMed ID: 25986372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
    Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
    Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.
    Charurat M; Oyegunle M; Benjamin R; Habib A; Eze E; Ele P; Ibanga I; Ajayi S; Eng M; Mondal P; Gebi U; Iwu E; Etiebet MA; Abimiku A; Dakum P; Farley J; Blattner W
    PLoS One; 2010 May; 5(5):e10584. PubMed ID: 20485670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004-2017).
    Aliyu A; Adelekan B; Andrew N; Ekong E; Dapiap S; Murtala-Ibrahim F; Nta I; Ndembi N; Mensah C; Dakum P
    AIDS Res Ther; 2019 Oct; 16(1):30. PubMed ID: 31594539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men.
    Aliyu MH; Blevins M; Megazzini KM; Parrish DD; Audet CM; Chan N; Odoh C; Gebi UI; Muhammad MY; Shepherd BE; Wester CW; Vermund SH
    Int Health; 2015 Nov; 7(6):405-11. PubMed ID: 26012740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.
    Grimsrud A; Balkan S; Casas EC; Lujan J; Van Cutsem G; Poulet E; Myer L; Pujades-Rodriguez M
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e55-66. PubMed ID: 24977472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).
    Jiamsakul A; Kiertiburanakul S; Ng OT; Chaiwarith R; Wong W; Ditangco R; Nguyen KV; Avihingsanon A; Pujari S; Do CD; Lee MP; Ly PS; Yunihastuti E; Kumarasamy N; Kamarulzaman A; Tanuma J; Zhang F; Choi JY; Kantipong P; Sim B; Ross J; Law M; Merati TP;
    HIV Med; 2019 Aug; 20(7):439-449. PubMed ID: 30980495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
    Meloni ST; Chang CA; Eisen G; Jolayemi T; Banigbe B; Okonkwo PI; Kanki PJ
    PLoS One; 2016; 11(10):e0164030. PubMed ID: 27764094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
    Tweya H; Feldacker C; Estill J; Jahn A; Ng'ambi W; Ben-Smith A; Keiser O; Bokosi M; Egger M; Speight C; Gumulira J; Phiri S
    PLoS One; 2013; 8(9):e75761. PubMed ID: 24086627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to Improve Antiretroviral Therapy Adherence Among Adolescents and Youth in Low- and Middle-Income Countries: A Systematic Review 2015-2019.
    Reif LK; Abrams EJ; Arpadi S; Elul B; McNairy ML; Fitzgerald DW; Kuhn L
    AIDS Behav; 2020 Oct; 24(10):2797-2810. PubMed ID: 32152815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.